abstract |
The present invention relates to a pharmaceutical formulation characterised in that it comprises mainly clobetasolpropionate, minoxidil, and 11 alpha-hydroxyprogesterone as active principles, as well as other excipients, vitamins and/or minerals, and it relates to the use of this formulation in the treatment of skin complaints, mainly in the symptomatic treatment of psoriasis. |